Skip to main
DLB

Dolby Laboratories (DLB) Stock Forecast & Price Target

Dolby Laboratories (DLB) Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Dolby Laboratories is poised to deliver high-single digit revenue growth with its expanding technology, including Atmos, Vision, and Image Patent Licensing, and is a strong company that enjoys support from its auto, television, and cinematic contributors. Atmos is expanding into the automobile and the company's number of licensees now exceeds 40, and, the company intends to increase its annual dividend by 2.7% along with a buyback good for $150 million, which will likely help further lower the maximum impact of COVID.

Bears say

Dolby Laboratories is experiencing continued dominance in content through social media partners in China and Meta, as well as in traditional Hollywood ecosystems. Its established presence in Apple's products and strides in Android and Windows devices demonstrate its ubiquity. Additionally, the company's patent portfolio enables streamers to offer high-quality content at lower costs, providing a path for potential growth independent of device cycles. These factors contribute to the analyst's Buy rating and $85 price target, as they reflect the company's strong operating margin and cash generation capabilities.

Dolby Laboratories (DLB) has been analyzed by 3 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Dolby Laboratories and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Dolby Laboratories (DLB) Forecast

Analysts have given Dolby Laboratories (DLB) a Buy based on their latest research and market trends.

According to 3 analysts, Dolby Laboratories (DLB) has a Buy consensus rating as of Aug 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $83, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $83, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Dolby Laboratories (DLB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.